Description:
This sessions highlight the selection and monitoring of critical quality attributes (CQA) to ensure desired performance in drug product during pharmaceutical development and/or manufacturing. The integration of empirical and theoretical process models with a control strategy is a focus of this session. The successes and challenges associated with advanced control strategies, such as model predictive control and multivariate control, are addressed. The scope of this session includes batch, semi-continuous, and continuous processes. Academic and industrial research involving the novel use of Process Analytical Tools for on-line monitoring of CQAs are explored. Applications of lab-based PAT to identify scalable process fingerprint and establish control strategy, as well as advancements in technologies and methods toward real-time monitoring and release are included.
Sponsor:
Pharmaceutical Discovery, Development and Manufacturing Forum
Co-Sponsor(s):
Process Development Division (12)
Co-chairs:
Christopher Marton
Chemical Process Development, Bristol Myers Squibb, Garwood, NJ
Qinglin Su
CONTINUUS Pharmaceuticals, Woburn, MA
Abstract Submissions Closed
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum